ALXO
USDALX Oncology Holdings Inc. Common Stock
Real-time Price
Price Chart
Key Metrics
Market Metrics
Open
$1.520
High
$1.600
Low
$1.460
Volume
0.54M
Company Fundamentals
Market Cap
78.2M
Industry
Biotechnology
Country
United States
Trading Stats
Avg Volume
0.93M
Exchange
NMS
Currency
USD
52-Week Range
Related News
ALX Oncology to Report Third Quarter 2025 Financial Results and Pipeline Progress Including Evorpacept CD47 Biomarker Data to be Presented at Upcoming SITC Annual Meeting
SOUTH SAN FRANCISCO, Calif., Oct. 30, 2025 (GLOBE NEWSWIRE) -- ALX Oncology Holdings Inc., ("ALX Oncology" or the "Company") (NASDAQ:ALXO), a clinical-stage biotechnology company advancing a pipeline of
ALX Oncology Announces Preclinical Data and Phase 1 Trial-in-Progress Presentations of ALX2004, a Novel EGFR-Targeted ADC, at 2025 AACR-NCI-EORTC Conference
-Two poster presentations showcase best- and first-in-class potential of ALX2004, a novel, antibody-drug conjugate (ADC) for the treatment of EGFR-expressing solid tumors -Robust body of preclinical data supports
Related Stocks
STAF
Staffing 360 Solutions Inc. (DE)
TRML
Tourmaline Bio Inc.
MINDP
MIND Technology Inc. Series A 9.00% Series A Cumulative Preferred Stock (DE)
LPTH
LightPath Technologies Inc.
PSN
Parsons Corporation
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.